ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO1133

Kidney Function, Albuminuria, and the Risk of Hemorrhage and Thrombosis After Kidney Transplantation

Session Information

Category: Transplantation

  • 1902 Transplantation: Clinical

Authors

  • Jeong, Rachel H., University of Alberta, Edmonton, Alberta, Canada
  • Quinn, Robert R., University of Calgary, Calgary, Alberta, Canada
  • Ravani, Pietro, University of Calgary, Calgary, Alberta, Canada
  • Sood, Manish M., Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
  • Tonelli, Marcello, University of Calgary, Calgary, Alberta, Canada
  • Ye, Feng, University of Alberta, Edmonton, Alberta, Canada
  • Hemmelgarn, Brenda, University of Calgary, Calgary, Alberta, Canada
  • Massicotte-Azarniouch, David, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
  • Lam, Ngan, University of Alberta, Edmonton, Alberta, Canada
Background

Compared to the general population, kidney transplant recipients are at increased risk of hemorrhage and thrombosis. Whether this risk is affected by kidney function and albuminuria is unknown.

Methods

We conducted a retrospective cohort study using linked healthcare databases to identify adult kidney transplant recipients from 2002-2015 in Alberta, Canada. Estimated glomerular filtration rate (eGFR) and albuminuria measurements at 1-year posttransplant were used to categorize recipients (eGFR: ≥45 vs. <45 mL/min/1.73 m2; albuminuria: normal vs. mild-heavy). We determined the association between categories of eGFR and albuminuria and posttransplant hemorrhage and venous thrombosis based on diagnostic and procedural codes.

Results

Of 1,284 kidney transplant recipients at 1-year posttransplant, 21% had an eGFR <45 mL/min/1.73 m2 and 40% had mild-heavy albuminuria. The mean age of the cohort was 53 years [IQR 41-62]. Previous thrombosis was higher in recipients with lower eGFR, but previous hemorrhage was similar across all groups. Over a median follow-up of 6 years, the age- and sex-adjusted rate of hemorrhage and thrombosis was over 2-fold higher in recipients with lower eGFR and mild-heavy albuminuria compared to recipients with higher eGFR and normal albuminuria (hemorrhage: incidence rate ratio, IRR, 2.6, 95% CI 1.5-4.4, p=0.001; thrombosis: IRR 2.3, 95% CI 1.1-5.0, p=0.046).

Conclusion

Among kidney transplant recipients at 1-year posttransplant, the risk of hemorrhage and venous thrombosis is higher with lower eGFR and mild-heavy albuminuria. Thus, eGFR and degree of albuminuria may help prognosticate kidney transplant recipients long-term.

Adjusted Incidence Rate Ratios by Level of eGFR and Albuminuria in Recipients